newsfilter
← Latest News
Business Wire·

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Bicycle Therapeutics plc (NASDAQ:BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the